title: Beta blocker treatment is associated with improvement in renal function and anaemia in patients with heart failure.
authors.forename: W
authors.initials: W
authors.lastname: Khan
authors.forename: S M
authors.initials: SM
authors.lastname: Deepak
authors.forename: T
authors.initials: T
authors.lastname: Coppinger
authors.forename: C
authors.initials: C
authors.lastname: Waywell
authors.forename: A
authors.initials: A
authors.lastname: Borg
authors.forename: L
authors.initials: L
authors.lastname: Harper
authors.forename: S G
authors.initials: SG
authors.lastname: Williams
authors.forename: N H
authors.initials: NH
authors.lastname: Brooks
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D003404:Creatinine / Q000378:metabolism; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000503:physiopathology; D012189:Retrospective Studies
chemical_list: D000319:Adrenergic beta-Antagonists; D003404:Creatinine